Dr. Barry Davis, Guy S. Parcel Chair in Public Health, Professor of Biostatistics, and Director of the Coordinating Center for Clinical Trials at The University of Texas School of Public Health, has co-authored more than 300 peer-reviewed publications, and is highly regarded nationally and internationally for his contributions to clinical trials. Show full bio
Dr. Davis has extensive experience in the leadership, design, analysis, oversight, and data management of multicenter clinical trials. He is past President and a Fellow of the Society for Clinical Trials. During the last 30 years, Dr. Davis has participated in and led numerous large-scale cardiovascular (particularly hypertension) clinical trials. Specifically, as PI or Co-I in the NHLBI sponsored Hypertension Detection and Follow-up Program (HDFP), Systolic Hypertension in the Elderly Program (SHEP), Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT, a world renowned pragmatic trial), and Genetics of Hypertension Associated Treatment (GenHAT) and in the industry-sponsored Cholesterol and Recurrent Events Trial (CARE).
Dr. Davis’ research has garnered over $200 million in extramural funding. He is a Fellow of the American Statistical Association and the American Association for the Advancement of Science and has served on numerous Data Monitoring Committees.
Interests
- Clinical Trials
- Hypertension
- Regenerative Medicine
Education
-
Undergraduate:
MIT (BS)
-
Postgraduate:
Brown University (PhD)
-
Medical School:
University of California San Diego School of Medicine (MD)
-
Internship:
Worcester City Hospital, University of Massachusetts
Academic & Clinical Affiliations
Certifications
- American Board of Preventative Health and General Preventative Medicine
Honors, Awards and Memberships
- President, Society for Clinical Trials
- Fellow, American Association for the Advancement of Science
- Fellow, American Statistical Association